INTRODUCTION
============

Human periodontitis is the most common infectious disease, and the global prevalence of severe periodontitis is more than 10% [@B1]. Cementum, a thin layer of mineralized tissue, plays an essential role in anchoring teeth to the surrounding alveolar bone. Consequently, cementum regeneration is considered a gold standard of successful periodontal tissue reconstruction [@B2]. Cementoblasts, the cells forming cementum, share a similar gene expression pattern to that of osteoblasts, including runt-related gene 2 (*Runx2*), *Osx*, and type I collagen (*Col 1*), *Ocn*, *Opn* and *Bsp* [@B3]-[@B6]. However, the exact molecular mechanisms regulating cementoblast differentiation are not fully elucidated.

Wnt signaling is critical for normal development of multicellular organisms by regulating cell proliferation, differentiation, and apoptosis [@B7]. Activation of the canonical Wnt/β-catenin signaling leads to the stabilization and accumulation of cytosolic β-catenin, which then translocates to the nucleus where it interacts with members of the LEF/TCF family of transcription factors, resulting in the transcription of Wnt-target genes [@B8], [@B9]. Recently, dental researchers have focused on the potential role of Wnt signaling during morphogenesis of periodontal tissues. Not only are there several key Wnt-responsive cells in periodontal tissues such as osteoblasts, periodontal ligament (PDL) cells, odontoblasts, and cementoblasts, but also Wnt signaling potentially controls the proliferation and differentiation process of these cells [@B10]-[@B12]. Wnt signaling is reported to inhibit cementoblast differentiation and promote proliferation *in vitro* [@B13]. In the adult Axin2^LacZ+/-^ incisor PDL, cells showing the highest level of Wnt responsiveness in the cementum-PDL tissue display the greatest proliferation. Conversely, cells with the lowest levels of Wnt responsiveness exhibit the greatest amount of cell differentiation [@B14]. Sclerostin (SOST), an antagonist of Wnt, is detected in cementocytes and mineralizing PDL cells [@B15], [@B16], and thicker acellular and cellular cementum is observed in the sclerostin knockout mice [@B17]. Interestingly, in individuals with VBD (van Buchem disease), SOST was either absent or greatly decreased in osteocytes and cementocytes, although this change was associated with increased bone formation, but no overt changes in cementum thickness [@B18].

OSX, the zinc finger-containing transcription factor, functions genetically downstream of Runx2 and down-regulates the canonical Wnt signaling pathway through activating DKK1 (a potent canonical Wnt antagonist) in osteoblasts [@B19]-[@B21]. It has been demonstrated that *Osx* is required for osteoblast differentiation [@B22]-[@B24] and postnatal cartilage formation [@B25]. Likewise, *Osx* is likely required for cementogenesis [@B6], [@B26]. For example, *Runx2* and *Osx* are co-localized in cementoblasts, and *Osx* is significantly upregulated in cementum on both compression and tension sides during orthodontic tooth movement [@B27]. Our recent studies showed that there is a close relationship between the temporal- and spatial-expression pattern of *Osx* and the formation of cellular cementum, and there is accelerated cementum formation in the 3.6-Col 1-Osx transgenic mouse line [@B26]. On the other hand, conditional deletion of *Osx* in mesenchymal cells by crossing the 2.3 kb *Col 1*-Cre and *Osx*loxP mice led to a sharp reduction in cellular cementum formation (including cementum mass and mineral deposition rate), although the detailed molecular mechanism remains unresolved.

In this study, we attempted to address how *Osx* controls cementoblasts using a combination of both *in vitro*and *in vivo* approaches. Our results demonstrated that *Osx* accelerates cementoblast differentiation in part through down-regulation of the Wnt/β-catenin signaling by activating DKK 1. This finding sheds light on the mechanisms by which *Osx* regulates cementoblast differentiation.

MATERIALS AND METHODS
=====================

Cell cultures and Plasmid constructs
------------------------------------

The mouse cementoblast cell line OCCM-30 [@B28] was maintained in Dulbecco\'s Modified Eagle\'s Medium (DMEM) supplemented with 10% FBS, 100U/ml penicillin G, and 100ug/ml streptomycin. The cells were cultured at 37℃ in humidified incubators with 5% CO~2~ and 95% air. *Osx* cDNA was amplified and cloned into EcoRI and BamHI sites of pIRES2 expression vector. The sequence of *Osx*cDNA was confirmed by DNA sequence analysis.

Mice
----

*Osx-lacZ*[@B29] knock-in mice, where *Osx* is replaced by a *lacZ* reporter [@B29], were used for tracing where *Osx*is expressed in the region of the PDL and cementum at the age of 6-weeks. To avoid neonatal death, mice harboring a floxed allele of *Osx* [@B30] were crossed to the *2.3 Col 1*-*Cre* mice [@B31] for tissue-specific deletion of *Osx*at the embryonic stage to cover early stage phenotype during cementogenesis. Genotyping was determined by polymerase chain reaction (PCR) analysis of genomic DNA with primers p01: 5\'-CGGGGAGTCCCGAGGACTCTG-3\' and p02: 5\'-CTGTCTTCACCTCAATTCTATT-3\' to detect the wild-type allele (\~400 base pairs \[bp\]) and *Osx*(\~550 bp); and primers p03: 5\'-CCCGCAGAACCTGAAGATG-3\' and primers p04: 5\'-GACCCGGCAAAACAGGTAG-3\' to detect the Cre allele (\~500 bp).

Reagents and Antibodies
-----------------------

Lithium chloride, ascorbic acid, Naβ-glycerophosphate and dexamethasone were purchased from Sigma Chemical Company (St Louis, MO, USA). Recombinant mouse DKK1 was obtained from R&D Systems (Minneapolis, MN, USA). Alkaline phosphatase activity assay kit was purchased from Jiancheng (Nanjing, China). Antimouse rabbit antibodies to OSX, β-catenin, OCN, OPN, and ALP were obtained from Abcam (Cambridge, MA, USA). Antimouse rabbit antibody to BSP II was obtained from Santa Cruz (CA, USA). Antimouse rabbit antibody to β-actin was obtained from Good bio (Wuhan, China).

Transient transfection, siRNA interference, RNA isolation, and Real-time RT-PCR
-------------------------------------------------------------------------------

The OCCM-30 cells were seeded in 60mm dishes in DMEM without antibiotics the day before transfection. The cells were transfected with 1μg of pIRES2-Osx plasmids or vectors with Lipofectamine 3000 according to manufacturer\'s instructions. In siRNA interference assay, 200 pmol *Osx* siRNA (5\'-GGAUAUGACUCAUCCCUAUTTT-3\' and 5\'-AUAGGGAUGAGUCAUAUCCTT-3) or NC siRNA (5\'-UUCUCCGAACGUGUCACGUTT-3\' and 5\'-ACGUGACACGUUCGGAGAATT-3\') were transfected into cells using Lipofectamine 2000 according to manufacturer\'s instruction. At the end of each time point (24 hr. or 48 hr. or 72 hr.), total RNA was extracted from cementoblasts with TRIzol reagent (Invitrogen, USA) according to the manufacturer\'s instructions. RNA was also extracted from cells stimulated with 10mM LiCl for 0, 3, 6, 12, 24, and 36hr. cDNAs were synthesized using Revert Aid^TM^First Strand cDNA Synthesis Kit (Fermentas, USA) according to the manufacturer\'s instructions. Real-time PCR was performed using the ABI 7500 system (Applied Biosystems) with SYBR® Premix Ex TaqTMII kit (TaKaRa, Japan). The amplification profile was 95℃ for 10 min, followed by 40 cycles at 95/5; 55/30; 72/30 \[temperature(℃)/time(s)\]. The PCR primer sequences for each gene, *Osx*, β-catenin, *Dkk1*, *Opn, Ocn, Bsp, Alp, Tcf 1, Gapdh*, are shown in Table [1](#T1){ref-type="table"}. Fold differences in gene expression were calculated according to the ΔΔCt method with normalization to GAPDH.

Western Blot
------------

After the cells were treated with 10mM LiCl for 3, 6, 12, 24hr or transfected for 36, 46 and 72hr respectively, the protein was extracted. Cells were rinsed twice with ice-cold PBS and lysed with 100ul Mammalian protein Extraction reagent (Thermo Scientific, China). The lysates were centrifuged for 15 minutes at 16,000×g at 4℃. Protein concentrations were determined using BCA Protein Assay Kit (Pierce). Total protein (20μg) was separated on 8% SDS-PAGE gels and transferred to PVDF membranes (Millipore). Five % milk in TBS containing 0.05%Tween-20 was used to block non-specific binding for 60 minutes. These membranes were immunoblotted separately with anti-OSX (1:1000), anti-β-catenin (1:5000), anti-OCN (1:800), anti-OPN (1:1000), or anti-BSP (1:500) overnight at 4℃. The membranes were washed three times (3×5 minutes) with TBS/0.05% Tween-20 and then incubated with horseradish peroxidase-conjugated anti-rabbit secondary antibodies (1:10,000) for 1 h. After another washing for 3×5 minutes, the membranes were detected with ECL Detection Reagents (Thermo Scientific) and exposed to x-ray film for detection of expression levels.

Immunofluorescence and immunohistochemistry assays
--------------------------------------------------

An immunofluorescence assay was performed to assess nuclear translocation of β-catenin and the expression of OPN, OCN, BSP and ALP. OCCM-30 cells were washed in PBS at indicated times, and fixed with 4% paraformaldehyde for 30 minutes at room temperature followed by permeabilization with PBS containing 0.1% Triton X-100 for 5 minutes. The cells were then incubated in PBS containing 5% BSA for 60 minutes at room temperature to block non-specific binding. Next, cells were incubated with anti-β-catenin (1:800), anti-OCN (1:200), anti-OPN (1:400), anti-BSP (1:100), or anti-ALP (1:50) overnight at 4℃ and washed three times with PBS. Cells were subsequently incubated with goat anti-rabbit secondary antibody (1:500) for 60 minutes at 37℃and washed three times with PBS. After staining with DAPI (Invitrogen) for 2 minutes, cover slips were mounted with anti-fluorescence quench reagent (Beyotime). Pictures were taken under an inverted fluorescence microscope. Immunostained mouse jaws were previously described [@B26], [@B32]. The *Osx* conditional knockout (cKO, the crossing between Osx-LoxP [@B30] and the 2.3 Col 1-Cre [@B31] mice), and control samples were obtained from the previous studies, in which we reported a great loss of cementum and mineral deposition rates [@B26].

Alkaline phosphatase activity assay
-----------------------------------

The cells were plated at density of 5×10^4^/well in 48-well plates. At 96hr after transfection or stimulation with 5mM or 10mM LiCl, the cells were washed three times with PBS, and then lysed with Mammalian protein Extraction reagent (Thermo Scientific) and centrifuged for 15 minutes at 16,000×g at 4℃. Five μl of supernatant was used to measure the protein content of each sample with BCA protein assay kit (Pierce). Thirty μl of supernatant was used to determine the ALP activity with an ALP activity assay kit according to the manufacturer\'s instructions. The enzyme activity was reported as U/g of protein.

Alizarin Red Staining
---------------------

The OCCM-30 cells were plated in 12-well plates (1×10^5^/well) and cultured in 5% CO~2~ at 37℃. Upon sub-confluence, the cells were replaced with or without LiCl and osteogenic medium containing 10 µM Naβ-glycerophosphate, 50μg/ml ascorbic acid and 0.1uM dexamethasone. The medium was changed every 3 days. After 2 weeks, the cells were fixed with 95% ethanol, treated with 2% Alizarin red staining (pH 4.2) for 15 min at 37℃, and then washed five times with PBS. After the photos of nodules were taken, 1ml 10% cetylpyridinium chloride was added into each well to dissolve the nodules, and the absorbance was examined at 562nm.

Statistical Analysis
--------------------

Results were reported as mean ±SD. The t-test and One-way ANOVA were used to evaluate statistical differences with GraphPad Prism 6. P\<0.05 was considered statistically significant.

RESULTS
=======

*Osx* accelerates cementoblast differentiation
----------------------------------------------

To study the function of Osx in cementoblast differentiation *in vitro*, we initially took the gain of function approach by transient transfection of the CMV-*Osx* expression plasmid into the cementoblast cell line. The forced increase in *Osx* at mRNA and protein levels (Fig. [1](#F1){ref-type="fig"}a) led to significant increases in the mRNA (Fig. [1](#F1){ref-type="fig"}b) and protein (Fig. [1](#F1){ref-type="fig"}c) levels of OPN, OCN, and BSP, as well as ALP activity (Fig. [1](#F1){ref-type="fig"}d). To confirm these observations, we used the loss of function (siRNA) approach and knocked down *Osx* mRNA and protein levels (Fig. [1](#F1){ref-type="fig"}e). As predicted, the down-regulation of *Osx*resulted in sharp reductions in expression of the above cementoblast markers, including expression levels of OPN, OCN and ALP (Fig. [1](#F1){ref-type="fig"}f), and ALP activities (Fig. [1](#F1){ref-type="fig"}g). In addition, immunostained images displayed pronounced decreases in these markers in *Osx* knockdown cementoblasts (Fig. [1](#F1){ref-type="fig"}h). Taken together, the above data are in agreement with the *in vivo* studies, in which *Osx* is shown to be critical for cementum growth during postnatal development [@B26].

*Osx* inhibits Wnt/β-catenin signaling in cementoblasts
-------------------------------------------------------

To understand the molecular mechanisms by which *Osx* controls cementoblast markers, we analyzed the expression of β-catenin responses to the overexpression or down-regulation of Osx. Unexpectedly, the forced expression of *Osx* inhibited β-catenin while knockdown of *Osx* enhanced β-catenin levels as visualized by Western blot (Fig. [2](#F2){ref-type="fig"}a) and nuclear translocation by immunofluorescent assay (Fig. [2](#F2){ref-type="fig"}b). Further, we showed corresponding changes of *Tcf1*expression by real time RT-PCR: overexpression of *Osx* significantly decreased *Tcf1* whereas *Osx* knockdown increased *Tcf1* expression (Fig. [2](#F2){ref-type="fig"}c). These experiments support the notion that *Osx* controls gene expression in cementoblasts by negative regulation of the β-catenin signaling pathway (i.e., maintaining a low level of β-catenin during cementoblast differentiation).

Over-activation of Wnt/β-catenin signaling by LiCl recaptures *Osx* knockdown effects on cementoblast differentiation
---------------------------------------------------------------------------------------------------------------------

To further test the above hypothesis, we examined the cellular effect of LiCl, the GSK-3β inhibitor that prevents degradation of β-catenin in the cytoplasm, including the time-dependent influence of LiCl on β-catenin and TCF-1. As expected, β-catenin protein levels were increased after 3h of treatment, with the peak increases at 12 and 24 hours [Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S1a). We found an increase in the nuclear translocation of β-catenin by immunofluorescence assay (Fig. S1b) and a time-dependent increase in *Tcf-1* expression by real-time RT-PCR (Fig. S1c). Analysis of gene expression changes in *Opn*, *Ocn* and *Bsp*, as well as ALP activity and the *in vitro* mineralization by LiCl at two dosages (5- and 10- mM) and two time points (24- and 36-hours) clearly showed that expression of these genes was suppressed in the cementoblast cell line treated with LiCl in a time- and dose-dependent manner (Fig. [3](#F3){ref-type="fig"}a). These observations were further supported by Western blot data (Fig. [3](#F3){ref-type="fig"}b), ALP activity (Fig. [3](#F3){ref-type="fig"}c) and Alizarin red stained mineralization studies (Fig. [3](#F3){ref-type="fig"}d). In summary, these *in vitro*results confirm the negative role of the β-catenin signaling pathway in the regulation of cementoblast differentiation and mineralization.

*Osx* negatively controls the Wnt/β-catenin signaling pathway by direct activation of DKK1, the potent inhibitor of Wnt/β-catenin signaling, during cementoblast differentiation *in vitro* and *in vivo*
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Recent studies suggest that the Wnt/β-catenin signaling negatively regulates cementogenic differentiation of adipose tissue-derived stem cells ([@B33] or cementoblast differentiation [@B13] likely through the positive regulation of cementoblast cell differentiation by DKK1. Thus, we examined whether the negative regulation of the Wnt/β-catenin signaling by *Osx* (Fig. [2](#F2){ref-type="fig"}) occurs via upregulation of DKK1 levels. Using transient transfection, we first showed that the forced expression of *Osx* significantly increased *Dkk1* mRNA levels (Fig. [4](#F4){ref-type="fig"}a; \>2.5-fold upregulation). We also demonstrated that *Osx* knockdown resulted in over 50% inhibition in DKK1 expression, which was completely reversed either by large of amount of recombinant Wnt3a or DKK1 (Fig. [4](#F4){ref-type="fig"}b). In addition, we confirmed that recombinant Wnt3a activates the nuclear translocation of β-catenin [Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S2a and c) and *Tcf-1* expression (Fig. S2b). As a result, mRNA (Fig. S2d) and protein (Fig. S2e) levels of cementoblast markers such as OPN, OCN, and BSP were reduced, concurrent with a 50% ALP activity reduction (Fig. S2f). Once again, all of these changes induced by Wnt3a were significantly blocked by pre-treatment with recombinant DKK1 (Fig. S2), supporting the key function of OSX in maintaining a low level of Wnt/β-catenin via enhancement of DKK1 expression in cementoblasts (Fig. [4](#F4){ref-type="fig"}c).

Because *Osx-lacZ* signal, reflecting the endogenous *Osx* expression level, is highly expressed in dental follicles (DF), the PDL, and bone cells (Fig. [4](#F4){ref-type="fig"}d), we tested DKK1 and β-catenin levels in the *Osx cKO* (crossing *Osx*floxed and 2.3 *Col 1*-Cre) mice. The immunostaining data revealed a sharp reduction in DKK1 (Fig. [4](#F4){ref-type="fig"}f) and a concurrent increase in β-catenin expression (Fig. [4](#F4){ref-type="fig"}f) in the DF and PDL, as well as in the odontoblasts (Od). Similarly, the same change pattern occurred in the *Osx*cKO bone tissues ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S3), further supporting our working hypothesis that OSX controls cementogenesis in part through the Wnt-β-catenin signaling pathway via an up-regulation of DKK1 (Fig. [4](#F4){ref-type="fig"}c).

DISCUSSION
==========

Postnatal cementum development requires the integration of multiple transcription factors and signaling molecules, including OSX and Wnt. It is clear that OSX is essential for cementogenesis based on a close relationship between a temporal- and spatial-expression pattern of *Osx* and formation of cellular cementum plus the gain- and loss-function studies ([@B26], although the molecular mechanisms by which OSX controls cellular cementoblasts remain uncertain. In this study, we used multiple techniques combining both *in vitro* and *in vivo*models, and demonstrated that during cementogenesis OSX negatively controls the Wnt-β-catenin signaling pathway via up-regulation of DKK1 to maintain a low level of Wnt-β-catenin during cementogenesis.

The Wnt-β-catenin signaling pathway is essential for almost all organ development, including tooth [@B34]. However, the role of Wnt-β-catenin signaling in cementogenesis is controversial. For example, Lim and colleagues showed that cementum is thicker in a genetic strain of mice in which Wnt signaling is elevated [@B35]. Similarly, Cho\'s lab reported an increase in cementum mass in mice with excessive Wnt-β-catenin [@B36], [@B37]. Further, Kuchler and colleagues reported an increased thickness of the cementum and a concomitant moderate decrease in the periodontal space width in *Sost* KO mice [@B17]. On the other hand, Nemoto and colleagues reported that in the cementoblast cell line Wnt signaling inhibits cementoblast differentiation and promotes proliferation [@B13]. Liu and colleagues showed that DKK1 stimulates but Wnt3 inhibits cementoblast differentiation of adipose tissue-deprived stem cells [@B38]. It is important to note that none of these groups compared the role of Wnt-β-catenin in cementum both *in vivo* and *in vitro*.

To better address the mechanism by which OSX controls cementogenesis through the Wnt-β-catenin pathway, we first used *in vitro*approaches (Figs. [1](#F1){ref-type="fig"}-[4](#F4){ref-type="fig"}) and confirmed that Wnt3a or LiCl indeed inhibits the expression of OPN, OCN, and BSP mRNA and protein levels, and reduces ALP activity and formation of mineralized nodules in cementoblasts. We next demonstrated that OSX enhances cementoblast differentiation but inhibits cell proliferation via reducing Wnt signaling pathway in cementoblasts, which is supported by the following evidence: 1) overexpression of O*sx* reduced β-catenin protein level; 2) inhibition of *Osx* expression by siRNA led to a strong nuclear translocation of β-catenin; and 3) overexpression of *Osx* decreased the transcriptional activity of TCF-1 by over 50%.

To explore the link between OSX and the Wnt signaling pathway, we identified the key role of DKK1 in bridging the WNT signaling and OSX function based on the following findings: overexpression of Osx leads to a significant decrease in the mRNA level of *Dkk1*, whereas knock-down of *Osx* results in an increase in *Dkk1* levels. Furthermore, we showed that addition of DKK1 to the culture medium partially reversed the negative regulation of WNT signaling in cementoblast differentiation. Finally, we re-examined the *Osx*cKO lower jaw we previously reported [@B26], and demonstrated that the sharp reduction in DKK1 expression in *Osx*cKO is directly correlated with a great increase in β-catenin expression (Fig. [4](#F4){ref-type="fig"} and [Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S3).

It is well documented that OSX, as a zinc finger-containing transcription factor, plays an essential role in osteoblast differentiation [@B19], [@B24], and that cementoblasts share phenotypical characteristics with osteoblasts in many aspects, such as expressing the common gene markers such as OPN, ALP, and OCN [@B3], [@B4], [@B39]. Furthermore, OSX has been shown to down-regulate the canonical Wnt signaling pathway by activating DKK1 in bone cells [@B21]. A recent study also showed that OSX can synchronously work with HIF-1α to further inhibit β-catenin activity [@B40]. Given the common features between cementoblasts and osteoblasts plus the similar regulation mechanism as that reported for the osteoblasts [@B6], [@B41], we propose that Wnt-β-catenin signaling must be kept a low level in cementoblasts during postnatal development, because a high level of Wnt-β-catenin signaling will lead to a greater mass of immature cementum due to an increase in cell proliferation coupled with a decrease in cell differentiation (Fig. [4](#F4){ref-type="fig"}c). This hypothesis seems in contrast to the promotion of the quiescence-to-proliferation switch by the Wnt signaling pathway in the early cementogenesis. However, we believe that this biphasic role of Wnt signaling during cementogenesis is essential. For example, in the early stage (i.e. before cementoblast formation), Wnt-β-catenin represses the quiescence-to-proliferation switch in early progenitor cells. In the late stage (i.e. during cementum formation), Wnt-β-catenin signaling must be kept at a low level, which will ensure the proliferation-to-differentiation transition. This may explain why the expanded cementum in the CA-β-catenin model is thicker but not fully matured [@B35].

In summary, we report for the first time OSX regulates the differentiation of cementoblasts by maintaining a low level of Wnt/β-catenin signaling via a positive regulation of DKK1. This finding will enhance our understanding of the regulation of Wnt-β-catenin signaling by OSX during cementogenesis. Although the current finding and interpretation is based on studies in cementoblasts, this model might be applied to other hard tissues such as bone and dentin.
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![**Overexpression of *Osx* accelerates but siRNA knock-down of Osx inhibits cementoblast differentiation *in vitro*.**(a) The cementoblast cell lines **(**OCCM) were transfected with either CMV-*Osx* expression plasmids or the empty vector, and RT-PCR (*left panel*) and Western blot (*right panel*) were performed to evaluate whether an increase in *Osx* mRNA and protein levels occured after transient transfection of *Osx* (T *Osx*); (b-c) Cementoblast differentiation markers such as OPN, OCN, and BSP were increased in the experimental group (green) at mRNA levels (b) and protein levels (c) compared to the control group; (d) The ALP assay revealed an increase in ALP activity by overexpression of Osx; (e) The siRNA technique was used to knock-down *Osx* at levels of mRNAs and protein; (f) The mRNA and protein levels of OPN, OCN, BSP, and ALP, and were significantly reduced in the cell transfected with siRNA; (g) ALP activity was significantly reduced in the treated group; and (h) The immunofluorescence staining images confirmed the above changes of OPN, OCN, BSP and ALP at the protein levels in the *Osx* knock-down group. The signal is in red and nuclear stain is blue. Scale bar, 10μm. Data represented as mean **±**SD of three separate experiments with five wells each time. Statistical differences: \*P\<0.05, \*\*P\<0.01.](ijbsv11p0335g001){#F1}

![**Overexpression of *Osx* inhibits and the *Osx* knock-down increases**β-**catenin signaling in cementoblasts.**(a) The Western blot images showed that overexpression of *Osx* leads to a reduction in β-catenin levels, whereas *Osx* knock-down results in an increase in β-catenin; (b) The immunofluorescence stain assay confirmed the above observation in the changes in β-catenin in the nucleus (β-catenin signal, red; DAPI stained nucleus, blue; Scale bar, 10μm); and (c) The real-time RT-PCR data showed a down-regulation of *Tcf1*by overexpression of *Osx* and up-regulation by *Osx* siRNA. Data were represented as mean ±SD of five wells each time with three separate experiments. Statistical differences: \*P\<0.05.](ijbsv11p0335g002){#F2}

![**Activation of Wnt/β-catenin signaling by LiCl recaptures the *Osx* knockdown effects on cementoblast differentiation.**(a) The real-time RT-PCR assays demonstrated a dose-dependent inhibition of the expression of OPN, OCN, and BSP in cells treated with 5- and 10-mMLiCl; (b)The Western blot images confirmed the inhibitions of OPN, OCN, and BSP at the protein levels; (c) The ALP assay showed a similar dose-dependent reduction of the enzyme activity; (d) The alizarin red-stained image (bottom) and semi-quantitative data based on color reaction (upper panel) demonstrated a dose-dependent reduction in mineralization. Data were represented as mean ±SD of five wells each time with three separate experiments. Statistical differences: \*P\<0.05; \*\*P\<0.01.](ijbsv11p0335g003){#F3}

![**The negative regulation of Wnt**/**β-catenin by OSX is in part through activation of DKK1.**(a) The RT-PCR analysis revealed that overexpression of *Osx* leads to up-regulation of *Dkk1*(*left panel*), and that *Osx* siRNA transfection results in a sharp reduction of *Dkk1* (*right panel*); (b) The RT-PCR analysis showed that overexpression of *Osx*leads to down-regulation of *Tcf-1*(*left panel*), and partially reverses the positive reaction of *Tcf-1* in response to Wnt3 (*right panel*); (c) The diagram summarizes the *in vitro* findings: OSX negatively regulates Wnt-β-catenin through activation of DKK1, the potent inhibitor of Wnt signaling; (d) The x-gal-stained image revealed the expression pattern of *Osx-lacZ* in dental follicles (DF), periodontal ligament (PDL), bone cells, and odontoblast (Od); (e) Immunostain images demonstrated a great reduction in the *Osx*cKO PDL and Od cells (*right panel; red and black arrows*); (f) Immunostained images revealed a sharp increase in β-catenin in the *Osx*cKO PDL and Od cells (*right panel*). Data represented as mean ±SD of five wells each time with three separate experiments. Statistical differences: \*P\<0.05; \*\*P\<0.01.](ijbsv11p0335g004){#F4}
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Primer sequence used for real-time RT-PCR

  gene        Primer sequences forward/reverse
  ----------- --------------------------------------------------
  OPN         GAGGAAACCAGCCAAGGTAAG/ AAAGCAAATCACTGCCAATCTC
  OCN         GAGGACCATCTTTCTGCTCACT/ CGGAGTCTGTTCACTACCTTATTG
  ALP         TGTGGAATACGAACTGGATGAG/ ATAGTGGGAATGCTTGTGTCTG
  BSP         AAAATGGAGACGGCGATAGTT/ GAGTGTGGAAAGTGTGGAGTTCT
  Osx         GAAAGGAGGCACAAAGAAG/ CACCAAGGAGTAGGTGTGTT
  β-catenin   GCAGTCTTACTTGGATTCTGGA/ AGCCTTGCTCCCATTCATAA
  DKK 1       GAGGTCCCGAAGTTGAGGTT/ GCAGAGAGCCATCATTGTAAAC
  TCF 1       GGACTCACCCTCGTATCTTCTG/ TGTTGCTGTATCTGTGGATTCTG
  GAPDH       GGAGATTGTTGCCATCAACGA/ GAAGACACCAGTAGACTCCACGACA
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